within Pharmacolibrary.Drugs.ATC.V;

model V09IX14
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.096 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 150 / 1000000,
    adminCount     = 1,
    Vd             = 0.00016,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Gallium (68Ga) gozetotide, also known as 68Ga-PSMA-11, is a radiopharmaceutical agent used in positron emission tomography (PET) imaging for the detection of prostate-specific membrane antigen (PSMA) expressing prostate cancer lesions. It is approved for diagnostic purposes in patients with prostate cancer and is not used for therapeutic applications.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in adult male patients with prostate cancer, healthy renal and hepatic function, following single intravenous administration for diagnostic PET imaging.</p><h4>References</h4><ol><li><p>Da Ros, V, et al., &amp; Garaci, F (2024). Intra-arterial administration of PSMA-targeted radiopharmaceuticals for brain tumors: is the era of interventional theranostics next?. <i>Expert review of anticancer therapy</i> 24(10) 925–929. DOI:<a href=&quot;https://doi.org/10.1080/14737140.2024.2398492&quot;>10.1080/14737140.2024.2398492</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/39206859/&quot;>https://pubmed.ncbi.nlm.nih.gov/39206859</a></p></li><li><p>Kohlbrenner, R, et al., &amp; Hope, TA (2024). Pharmacokinetic Comparison of Selective Prostatic Arterial and Intravenous PSMA PET/CT Radioligand Infusions in Primary Prostatic Adenocarcinoma. <i>Radiology</i> 312(2) e232544–None. DOI:<a href=&quot;https://doi.org/10.1148/radiol.232544&quot;>10.1148/radiol.232544</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/39136560/&quot;>https://pubmed.ncbi.nlm.nih.gov/39136560</a></p></li><li><p>Inaki, A, et al., &amp; Kinuya, S (2024). Evaluation of . <i>Annals of nuclear medicine</i> 38(8) 587–595. DOI:<a href=&quot;https://doi.org/10.1007/s12149-024-01931-7&quot;>10.1007/s12149-024-01931-7</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/38750331/&quot;>https://pubmed.ncbi.nlm.nih.gov/38750331</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end V09IX14;
